Life-Course Regulation of Health and Disease by Nitric Oxide: Mechanistic Insights
Antioxidants · 01.04.2026 · 15 (4) · 439
DOI: 10.3390/antiox15040439 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 01.04.2026. Verfasst von Chien-Ning Hsu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 801, Taiwan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, Kaohsiung Chang Gung Memorial Hospital.
Abstract (Originalsprache)
Nitric oxide (NO) functions as a master integrative regulator of cardiovascular–kidney–metabolic (CKM) homeostasis, yet it displays a profound Janus face, defined by concentration- and context-dependent roles in both health and disease. This narrative review examines NO signaling from a life-course perspective, beginning with fetal programming, during which the NO–asymmetric dimethylarginine (ADMA) axis orchestrates placental development and nephron endowment. Perturbations during this critical window—such as maternal ADMA elevation—can imprint a maladaptive trajectory toward adult-onset hypertension and chronic kidney disease. In adulthood, this initially silent dysregulation of NO signaling is amplified by Western dietary patterns and environmental pollutants, culminating in the clinical manifestation of the CKM triad. This pathological transition is driven by eNOS uncoupling and ADMA accumulation, which shift redox balance toward peroxynitrite formation and precipitate mitochondrial bioenergetic failure. Moreover, while constitutive NO production is essential for vascular homeostasis, pathological induction of inducible NOS generates excessive NO fluxes that promote insulin resistance and tissue injury. With advancing age, a progressive loss of NO resilience further exacerbates multi-organ vulnerability. To mitigate the cumulative burden of CKM disease, this review highlights developmental reprogramming strategies—such as perinatal L-citrulline supplementation and ADMA-lowering interventions—as interventions to restore physiological NO signaling. Integrating such early-life strategies with contemporary pharmacological therapies offers a coherent framework for maintaining NO bioavailability and extending health span across the life course.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 801, Taiwan.
- Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- School of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
- Doctoral Program of Clinical and Experimental Medicine, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
- College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.
ORCID-Profile: Chien-Ning Hsu, You-Lin Tain
Förderung
- National Science and Technology Council, Taiwan
- Kaohsiung Chang Gung Memorial Hospital
Zitieren
APA
Hsu, C. N., & Tain, Y. L. (2026). Life-Course Regulation of Health and Disease by Nitric Oxide: Mechanistic Insights. Antioxidants, 15(4), 439. https://doi.org/10.3390/antiox15040439
Vancouver
Hsu CN, Tain YL. Life-Course Regulation of Health and Disease by Nitric Oxide: Mechanistic Insights. Antioxidants. 2026;15(4):439. doi:10.3390/antiox15040439
BibTeX
@article{Hsu2026,
author = {Hsu, Chien-Ning and Tain, You-Lin},
title = {Life-Course Regulation of Health and Disease by Nitric Oxide: Mechanistic Insights},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {4},
pages = {439},
doi = {10.3390/antiox15040439}
}
EUVIMED